Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Sichuan Hebang Biotechnology CoSHSE:603077 +2.10%53 Return-on-Tangible-Asset is 3.28% as of Jun. 2026, which is 17% below its 10-year median of 3.97. GuruFocus rates SHSE:603077 with a GF Score™ of 53/100 and a GF Value™ of ¥1.26 (Significantly Overvalued). The stock has 8 warning signs investors should review. Among 1,618 Chemicals companies, Sichuan Hebang Biotechnology Co ranks worse than 77.75% on this metric.
The historical rank and industry rank for Sichuan Hebang Biotechnology Co's Return-on-Tangible-Asset or its related term are showing as below:
SHSE:603077'
s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: -2.05 Med: 3.97 Max: 21.65
Current: -0.82
During the past 13 years, Sichuan Hebang Biotechnology Co's highest Return-on-Tangible-Asset was 21.65%. The lowest was -2.05%. And the median was 3.97%.
SHSE:603077's Return-on-Tangible-Asset is ranked worse than 77.75% of 1618
companies
in the Chemicals industry
Industry Median: 3.625
vs SHSE:603077: -0.82
Sichuan Hebang Biotechnology Co (SHSE:603077) Return-on-Tangible-Asset Explanation
Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.
Be Aware
Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the companys earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a companys tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.
Sichuan Hebang Biotechnology Co Return-on-Tangible-Asset Related Terms
Sichuan Hebang Biotechnology Co Return-on-Tangible-Asset Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sichuan Hebang Biotechnology Co Return-on-Tangible-Asset Chart
SHSE:603077 vs DOW: Return-on-Tangible-Asset Comparison
For the Chemicals subindustry, Sichuan Hebang Biotechnology Co's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sichuan Hebang Biotechnology Co Return-on-Tangible-Asset vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Sichuan Hebang Biotechnology Co's Return-on-Tangible-Asset distribution charts can be found below:
* The bar in red indicates where Sichuan Hebang Biotechnology Co's Return-on-Tangible-Asset falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is four times the quarterly (Jun. 2026) net income data.
What does a Return-on-Tangible-Asset of 3.28% mean?
Sichuan Hebang Biotechnology Co (SHSE:603077) has a Return-on-Tangible-Asset of 3.28% as of Jun. 2026. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Sichuan Hebang Biotechnology Co and its competitors. This is 17% below median its historical median of 3.97. According to the industry distribution chart, Sichuan Hebang Biotechnology Co ranks #1258 out of 1618 companies in the Chemicals industry, placing it in the top 77.8%.
Is Sichuan Hebang Biotechnology Co's Return-on-Tangible-Asset too high?
Sichuan Hebang Biotechnology Co's current Return-on-Tangible-Asset of 3.28% is 17% below median its 10-year median of 3.97. The Chemicals industry median Return-on-Tangible-Asset is 3.63. Sichuan Hebang Biotechnology Co's value of 3.28% is 9.5% below this industry median. Based on the distribution chart, Sichuan Hebang Biotechnology Co ranks #1258 out of 1618 companies in the Chemicals industry, which is in the bottom quartile relative to peers. Overall, Sichuan Hebang Biotechnology Co has a GF Score™ of 53/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Sichuan Hebang Biotechnology Co's Return-on-Tangible-Asset compare to DOW?
According to the Chemicals industry distribution chart, Sichuan Hebang Biotechnology Co ranks #1258 out of 1618 companies for Return-on-Tangible-Asset. This places Sichuan Hebang Biotechnology Co in the lower half of its industry. The industry median Return-on-Tangible-Asset is 3.63. Sichuan Hebang Biotechnology Co's value of 3.28% is 9.5% below this benchmark. While the company's 10-year median is 3.97 vs. the industry median of 3.63, Sichuan Hebang Biotechnology Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Asset for a Chemicals company?
The median Return-on-Tangible-Asset among Chemicals companies is 3.63, based on 1,618 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Asset significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sichuan Hebang Biotechnology Co's current Return-on-Tangible-Asset of 3.28% is 9.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Asset mean?
A high Return-on-Tangible-Asset can signal that a stock is expensive relative to its fundamentals. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Sichuan Hebang Biotechnology Co and its competitors. For the Chemicals industry, the median Return-on-Tangible-Asset is 3.63 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sichuan Hebang Biotechnology Co's current Return-on-Tangible-Asset is 3.28%, which is 17% below median its own 10-year median of 3.97. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sichuan Hebang Biotechnology Co stock overvalued right now?
Based on GuruFocus' analysis, Sichuan Hebang Biotechnology Co (SHSE:603077) is currently considered Significantly Overvalued. The stock's GF Value™ is ¥1.26, compared to a current price of ¥2.43 — trading 92.9% above its estimated fair value. The current Return-on-Tangible-Asset is 3.28%, which is 17% below median its 10-year median of 3.97 and 9.5% below the Chemicals industry median of 3.63. Sichuan Hebang Biotechnology Co's overall GF Score™ is 53/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Asset calculated?
Return-on-Tangible-Asset is calculated from a company's financial statements. For Sichuan Hebang Biotechnology Co (SHSE:603077), the current Return-on-Tangible-Asset is 3.28% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sichuan Hebang Biotechnology Co (SHSE:603077) Overvalued in 2026?
Based on GuruFocus' analysis, Sichuan Hebang Biotechnology Co stock appears to be overvalued.
The current stock price of ¥2.43 is trading 92.9% above its estimated GF Value™ of ¥1.26.
GuruFocus considers Sichuan Hebang Biotechnology Co to be Significantly Overvalued.
Key valuation signals for SHSE:603077:
Return-on-Tangible-Asset: 3.28% (17% below median its 10-year median of 3.97)
GF Value™: ¥1.26 vs. price of ¥2.43 (92.9% above fair value)
Industry Position: 9.5% below the Chemicals median (#1258 of 1618)
No single metric tells the full story. See the SHSE:603077 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:603077 has been successfully added to your 
